Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14371
Abstract: Cutaneous squamous cell carcinomas (CSCC) are one of the most frequent types of cancer, with rising incidence rates(1). While the majority are cured with surgery, some CSCC are associated with significant morbidity and mortality due… read more here.
Keywords: cell; squamous cell; response pembrolizumab; major response ... See more keywords